DR. FRANK JOHN GRESKOVICH M.D. NPI 1285611236

NPI Details

DR. Frank John Greskovich, M.D. is an urology in Pensacola, FL with 42 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Frank John Greskovich, M.D. NPI is 1285611236. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1984

The provider's business location address is:

4724 N DAVIS HWY
PENSACOLA, FL
ZIP 32503-339
Phone: (850) 696-4000
Fax: (850) 444-7057

The NPI 1285611236 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Injection, gadobenate dimeglumine (multihance), per ml (HCPCS:A9577)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Blood creatinine level (HCPCS:82565)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Simple change of bladder tube (HCPCS:51705)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• X-ray of chest, 2 views (HCPCS:71046)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 12/29/2005 and was last updated on 6/20/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.